You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
|
|---|---|
| Published in |
Molecular Cancer, November 2019
|
| DOI | 10.1186/s12943-019-1091-2 |
| Pubmed ID | |
| Authors |
Shuang Qin, Linping Xu, Ming Yi, Shengnan Yu, Kongming Wu, Suxia Luo |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 727 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 727 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 106 | 15% |
| Researcher | 99 | 14% |
| Student > Bachelor | 88 | 12% |
| Student > Master | 65 | 9% |
| Student > Doctoral Student | 40 | 6% |
| Other | 79 | 11% |
| Unknown | 250 | 34% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 134 | 18% |
| Medicine and Dentistry | 106 | 15% |
| Immunology and Microbiology | 89 | 12% |
| Agricultural and Biological Sciences | 40 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 33 | 5% |
| Other | 50 | 7% |
| Unknown | 275 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 October 2023.
All research outputs
#1,614,299
of 24,584,609 outputs
Outputs from Molecular Cancer
#83
of 1,851 outputs
Outputs of similar age
#35,628
of 371,945 outputs
Outputs of similar age from Molecular Cancer
#2
of 35 outputs
Altmetric has tracked 24,584,609 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,851 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.5. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 371,945 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.